PHCUF
Price
$5.87
Change
-$0.13 (-2.17%)
Updated
Aug 7 closing price
Capitalization
162.82M
SFOSF
Price
$2.85
Change
+$0.01 (+0.35%)
Updated
Sep 4 closing price
Capitalization
10.66B
Interact to see
Advertisement

PHCUF vs SFOSF

Header iconPHCUF vs SFOSF Comparison
Open Charts PHCUF vs SFOSFBanner chart's image
Photocure ASA
Price$5.87
Change-$0.13 (-2.17%)
Volume$1K
Capitalization162.82M
Shanghai Fosun Pharmaceutical Group
Price$2.85
Change+$0.01 (+0.35%)
Volume$120
Capitalization10.66B
PHCUF vs SFOSF Comparison Chart in %
Loading...
PHCUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SFOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHCUF vs. SFOSF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHCUF is a Hold and SFOSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (PHCUF: $5.87 vs. SFOSF: $2.85)
Brand notoriety: PHCUF and SFOSF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PHCUF: 171% vs. SFOSF: 13%
Market capitalization -- PHCUF: $162.82M vs. SFOSF: $10.66B
PHCUF [@Pharmaceuticals: Generic] is valued at $162.82M. SFOSF’s [@Pharmaceuticals: Generic] market capitalization is $10.66B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHCUF’s FA Score shows that 1 FA rating(s) are green whileSFOSF’s FA Score has 1 green FA rating(s).

  • PHCUF’s FA Score: 1 green, 4 red.
  • SFOSF’s FA Score: 1 green, 4 red.
According to our system of comparison, SFOSF is a better buy in the long-term than PHCUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHCUF’s TA Score shows that 2 TA indicator(s) are bullish while SFOSF’s TA Score has 3 bullish TA indicator(s).

  • PHCUF’s TA Score: 2 bullish, 2 bearish.
  • SFOSF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, SFOSF is a better buy in the short-term than PHCUF.

Price Growth

PHCUF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while SFOSF (@Pharmaceuticals: Generic) price change was +23.91% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SFOSF($10.7B) has a higher market cap than PHCUF($163M). PHCUF has higher P/E ratio than SFOSF: PHCUF (772.72) vs SFOSF (16.69). SFOSF YTD gains are higher at: 58.307 vs. PHCUF (4.907). SFOSF has higher annual earnings (EBITDA): 5.91B vs. PHCUF (44.5M). SFOSF has more cash in the bank: 16.1B vs. PHCUF (239M). PHCUF has less debt than SFOSF: PHCUF (0) vs SFOSF (36.2B). SFOSF has higher revenues than PHCUF: SFOSF (40.3B) vs PHCUF (523M).
PHCUFSFOSFPHCUF / SFOSF
Capitalization163M10.7B2%
EBITDA44.5M5.91B1%
Gain YTD4.90758.3078%
P/E Ratio772.7216.694,631%
Revenue523M40.3B1%
Total Cash239M16.1B1%
Total Debt036.2B-
FUNDAMENTALS RATINGS
PHCUF vs SFOSF: Fundamental Ratings
PHCUF
SFOSF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9282
PRICE GROWTH RATING
1..100
4838
P/E GROWTH RATING
1..100
651
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SFOSF's Valuation (25) in the null industry is significantly better than the same rating for PHCUF (98). This means that SFOSF’s stock grew significantly faster than PHCUF’s over the last 12 months.

SFOSF's Profit vs Risk Rating (100) in the null industry is in the same range as PHCUF (100). This means that SFOSF’s stock grew similarly to PHCUF’s over the last 12 months.

SFOSF's SMR Rating (82) in the null industry is in the same range as PHCUF (92). This means that SFOSF’s stock grew similarly to PHCUF’s over the last 12 months.

SFOSF's Price Growth Rating (38) in the null industry is in the same range as PHCUF (48). This means that SFOSF’s stock grew similarly to PHCUF’s over the last 12 months.

PHCUF's P/E Growth Rating (6) in the null industry is somewhat better than the same rating for SFOSF (51). This means that PHCUF’s stock grew somewhat faster than SFOSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHCUFSFOSF
RSI
ODDS (%)
Bearish Trend 4 days ago
11%
Bearish Trend 4 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
37%
Bearish Trend 4 days ago
81%
Momentum
ODDS (%)
Bullish Trend 4 days ago
30%
Bullish Trend 4 days ago
45%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
29%
Bullish Trend 4 days ago
51%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
26%
Bullish Trend 4 days ago
45%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
57%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
22%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PHCUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SFOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CUT30.990.41
+1.36%
Invesco MSCI Global Timber ETF
EWS28.530.24
+0.85%
iShares MSCI Singapore ETF
FPAS25.600.11
+0.44%
FPA Short Duration Government ETF
SCHG30.80-0.03
-0.10%
Schwab US Large-Cap Growth ETF™
SMLV133.08-0.15
-0.11%
SPDR® SSGA US Small Cap Low Volatil ETF

PHCUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHCUF has been loosely correlated with HLTRF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PHCUF jumps, then HLTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHCUF
1D Price
Change %
PHCUF100%
N/A
HLTRF - PHCUF
38%
Loosely correlated
N/A
INCR - PHCUF
26%
Poorly correlated
+0.27%
ELAN - PHCUF
24%
Poorly correlated
+5.50%
MKKGY - PHCUF
22%
Poorly correlated
+1.66%
MKGAF - PHCUF
20%
Poorly correlated
+1.49%
More

SFOSF and

Correlation & Price change

A.I.dvisor tells us that SFOSF and BIOVF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SFOSF and BIOVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SFOSF
1D Price
Change %
SFOSF100%
N/A
BIOVF - SFOSF
21%
Poorly correlated
N/A
TKPHF - SFOSF
7%
Poorly correlated
+11.86%
PHCUF - SFOSF
7%
Poorly correlated
N/A
SGIOF - SFOSF
5%
Poorly correlated
N/A
TCNNF - SFOSF
3%
Poorly correlated
+4.55%
More